Stock 4172 INNOPHARMAX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company InnoPharmax Inc.

Equities

4172

TW0004172002

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 27/05/2024 am IST 		5-day change 1st Jan Change
15.95 TWD -0.62% Intraday chart for InnoPharmax Inc. -2.45% -8.33%
19/04 InnoPharmax Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 InnoPharmax Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Innopharmax Inc is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company mainly provides generic drugs, including Cyclosporine A, Tacrolimus, Imipenem, Cilastatin, Gadodiamide, Gadopentetate, Levodopa, Carbidopa and Entacapone, as well as new drugs, including Gemcitabine Oral, Bendamustine, AB01001 patch and Carvedilol CR, among others. The Company mainly distributes its products within domestic market.

Number of employees: 34

Sales per Business

TWD in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
29 100.0 % 46 100.0 % +58.15%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
62.0 %
29 100.0 % 29 62.0 % -1.98%
China
35.9 %
-- 17 35.9 % -
Others
2.1 %
-- 1 2.1 % -

Managers

Managers TitleAgeSince
Wei Hua Hao CEO
 Chief Executive Officer - -
Ssu Ju Chen DFI
 Director of Finance/CFO - 01/22/01
Yu Tsai Yang CTO
 Chief Tech/Sci/R&D Officer - 21/21/21

Members of the board

Members of the board TitleAgeSince
Chih Hui Lin CHM
 Chairman - -
Wei Hua Hao CEO
 Chief Executive Officer - -
Han Pin Kuo BRD
 Director/Board Member - 29/12/29
Wei Lien Chung BRD
 Director/Board Member - -
Li Hang Fang BRD
 Director/Board Member - 15/15/15
Ku Tung Lin BRD
 Director/Board Member - 27/21/27
Hsueh Ju Tseng BRD
 Director/Board Member - 25/18/25
Hui Lan Chiu BRD
 Director/Board Member - 27/21/27
Chi Jui Li BRD
 Director/Board Member - 19/22/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 94,988,050 93,878,285 ( 98.83 %) 0 98.83 %

Company contact information

InnoPharmax, Inc.

9/F, 20, 9/F, 22, Lane 478 Ruiguang Road

114724, Taipei

+

http://www.innopharmax.com.tw
address InnoPharmax Inc.(4172)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
INNOPHARMAX INC. Stock InnoPharmax Inc.
-8.33% 4.73Cr
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+16.40% 4.29TCr
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+16.32% 2.14TCr
SANDOZ GROUP AG Stock Sandoz Group AG
+20.14% 1.51TCr
CIPLA LIMITED Stock Cipla Limited
+18.64% 1.44TCr
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+53.58% 1.3TCr
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 678.76Cr
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-12.64% 672.16Cr
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.64% 546.52Cr
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4172 Stock
  4. Company InnoPharmax Inc.